Drug Development

How Decades Of Research Misconduct Stalled An Alzheimer’s Cure

A whistleblower exposed fraudulent research supporting the amyloid hypothesis in Alzheimer's disease, revealing decades of scientific misconduct. The investigation unveiled how the dominant theory about amyloid plaques has potentially hindered progress toward finding an effective cure, while recent treatments like Leqembi show only minimal benefits.

Migraine is more than a headache — a radical rethink offers hope to one billion people

Medical advances, including gepants and related treatments, have redefined migraine as a manageable condition, moving beyond historical misconceptions of it being purely psychological or vascular. Brain research reveals migraine as a complex neurological condition involving the hypothalamus and limbic system, with various triggers affecting different people differently. Recent developments in CGRP-blocking drugs have shown promising results for some patients, though they're effective for only a subset of people.